Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions
A. Richey Sharrett(Baylor College of Medicine), Wolfgang Patsch(Paracelsus Medical University), Gerardo Heiss(University of North Carolina at Chapel Hill), Christie M. Ballantyne(Manpower Demonstration Research Corporation), Sean A. Coady(University of North Carolina at Chapel Hill), Paul D. Sorlie(University of North Carolina at Chapel Hill), Diane Catellier(University of North Carolina at Chapel Hill)
Cited by 938
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k